By utilizing databases of existing approved drug-target genes and protein–protein interactions (PPIs), Okada et al. demonstrated that GWAS-identified rheumatoid arthritis (RA)-susceptibility genes were significantly correlated with the targets of known RA drugs, such as TNF-inhibitors [17] and JAK inhibitors [18], via the PPI networks [19]. Here, TNF is linked to rheumatoid arthritis.